Profile picture

Professor Allan Lawrie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
Follow
Biography
Professor Allan Lawrie is Professor of Pulmonary Vascular Diseases at the National Heart and Lung Institue, Imperial College London. His research focuses on translational discoveries in cardiovascular and pulmonary vascular disease, with a particular emphasis on mechansitic biology, biomakers, digital health, remote monitoring, and data-driven approaches to disease prevention and management. He leads interdisciplinary programmes that integrate biological insights with smartphones, wearables, electronic health records, and AI to improve early detection, risk prediction, and personalised care. Through international collaborations spanning academia, healthcare, and industry, he works to accelerate the adoption of innovative technologies that improve cardiovascular and respiratory health outcomes.
Logo ESC

Contributor content

Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy
Journal
Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy
7 September 2026
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
Journal
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
19 November 2025
Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?
Journal
Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?
4 July 2025